Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roche, BioLamina partner to develop new cell culture systems
As per the agreement, Roche will provide R&D funding and scientific support to BioLamina. The financial terms and conditions of the deal were undisclosed. Roche’s Biochemical Reagents and
As per the agreement, Roche will provide R&D funding and scientific support to BioLamina. The financial terms and conditions of the deal were undisclosed. Roche’s Biochemical Reagents and
Since 2008, DKSH Healthcare is providing Market Expansion Services to Advance Pharma in West Malaysia. The extended partnership between DKSH and Advance Pharma in Malaysia aims to demonstrate
The approved patent application, which is part of the ‘Pan’ patent family, is designed to restore vision in retinal degenerative conditions such as retinitis pigmentosa and dry age-related
Ajinomoto said based upon a successful proof-of-concept, the company has entered a full licensing agreement that allows for the in-house use of the system. Corynex uses the gram-positive
The licensing agreement provides miRagen with exclusive rights to an important discovery made in collaboration with the University of Glasgow and the University of Cambridge, enabling miRagen to
The partnership aims to provide drug developers with improved access to pharmaceutical nanomilling equipment and full pharmaceutical development capabilities. Particle Sciences pharmaceutical development president Robert Lee said the
FDA in the letter mentioned that it requires Mallinckrodt’s complete pharmacokinetic study comparing PENNSAID 2% to original PENNSAID 1.5%. FDA denied to review the similar pharmacokinetic studies submitted
According to the firm, the lower dose submicron diclofenac NDA submission included data from a study conducted on 428 healthy adults in a Phase 3 multi-center, randomized process,
The sNDA filed is to expand the indication for ferumoxytol for the treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD), who have
As per the alliance, PolyPid will develop the new product, which will be based on BonyPid PolyPid’s product family, that can also treat specific dental problems requiring local,